Fatal and nonfatal opioid overdose risk following release from prison: A retrospective cohort study using linked administrative data

被引:18
|
作者
Hartung, Daniel M. [1 ,4 ]
McCracken, Caitlin M. [1 ]
Nguyen, Thuan [2 ]
Kempany, Katherine [3 ]
Waddell, Elizabeth Needham [2 ]
机构
[1] Oregon State Univ, Coll Pharm, Portland, OR USA
[2] Oregon Hlth & Sci Univ, OHSU Portland State Univ Sch Publ Hlth, Portland, OR USA
[3] Oregon Dept Correct, Salem, OR USA
[4] Oregon State Univ, Oregon Hlth & Sci Univ, Robertson Collaborat Life Sci Bldg RLSB,2730 S Moo, Portland, OR 97201 USA
关键词
Opioid overdose; Prison; Criminal justice; RANDOMIZED CONTROLLED-TRIAL; NALTREXONE XR-NTX; METHADONE-MAINTENANCE; USE DISORDER; INCARCERATED PERSONS; CLINICAL-TRIAL; UNITED-STATES; OPEN-LABEL; DRUG; DEATHS;
D O I
10.1016/j.josat.2023.208971
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Among individuals who are released from prison, opioid overdose is a leading cause of death with a risk more than ten-fold the general population. Although the epidemiology of opioid-related fatalities has been described, few studies have characterized both fatal and nonfatal opioid-related poisonings. The objective of this study was to estimate risk of fatal and nonfatal opioid overdose among adults released from prison.Methods: The study estimated fatal and nonfatal opioid overdose rates using linked corrections, Medicaid, hospital discharge, and vital statistics from the state of Oregon from 2014 to 2018. Multivariable proportional hazards models identified demographic and prison-related factors associated with overdose.Results: Between 2014 and 2017, 18,258 individuals were released from prison. A majority of individuals were male (87 %) and ages 26 to 64 (83 %). Two-thirds had a documented substance use disorder treatment need and 20 % demonstrated mental health treatment need. Following prison release, 579 opioid overdose events occurred; 65 (11 %) were fatal. The rate of opioid overdose was 1085.7 per 100,000 person-years (PY). Rates were highest in the first two weeks (2286.7 per 100,000 PY), among women (1582.9 per 100,000 PY), and those with mental health (1624.3 per 100,000 PY) or substance use disorder treatment needs (1382.6 per 100,100 PY). Only mental health (adjusted hazard ratio [aHR] 1.54, 95 % CI 1.24 to 1.90) and substance use need (aHR 2.59; 95 % CI 2.01 to 3.34) remained significant in multivariable models.Conclusions: The rate of opioid overdose is markedly elevated after prison release, particularly in the first two weeks. In women, the higher rate of opioid overdose is mediated by a greater mental health burden.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Risk factors for avoidable hospitalizations in Canada using national linked data: A retrospective cohort study
    Wallar, Lauren E.
    Rosella, Laura C.
    PLOS ONE, 2020, 15 (03):
  • [22] Incidence and prevalence of dementia in linked administrative health data in Saskatchewan, Canada: a retrospective cohort study
    Kosteniuk, Julie G.
    Morgan, Debra G.
    O'Connell, Megan E.
    Kirk, Andrew
    Crossley, Margaret
    Teare, Gary F.
    Stewart, Norma J.
    Dal Bello-Haas, Vanina
    Forbes, Dorothy A.
    Innes, Anthea
    Quail, Jacqueline M.
    BMC GERIATRICS, 2015, 15
  • [23] Incidence and prevalence of dementia in linked administrative health data in Saskatchewan, Canada: a retrospective cohort study
    Julie G. Kosteniuk
    Debra G. Morgan
    Megan E. O’Connell
    Andrew Kirk
    Margaret Crossley
    Gary F. Teare
    Norma J. Stewart
    Vanina Dal Bello-Haas
    Dorothy A. Forbes
    Anthea Innes
    Jacqueline M. Quail
    BMC Geriatrics, 15
  • [24] Association between opioid use disorder and palliative care: a cohort study using linked health administrative data in Ontario, Canada
    Lau, Jenny
    Scott, Mary M.
    Everett, Karl
    Gomes, Tara
    Tanuseputro, Peter
    Jennings, Sheila
    Bagnarol, Rebecca
    Zimmermann, Camilla
    Isenberg, Sarina R.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (16) : E547 - E557
  • [25] Non-fatal overdose risk associated with prescribing opioid agonists concurrently with other medication: Cohort study conducted using linked primary care, secondary care and mortality records
    Domzaridou, Eleni
    Carr, Matthew J.
    Millar, Tim
    Webb, Roger T.
    Ashcroft, Darren M.
    ADDICTION, 2023, 118 (12) : 2374 - 2383
  • [26] Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study
    Pearce, Lindsay A.
    Min, Jeong Eun
    Piske, Micah
    Zhou, Haoxuan
    Homayra, Fahmida
    Slaunwhite, Amanda
    Irvine, Mike
    McGowan, Gina
    Nosyk, Bohdan
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 368
  • [27] Comparing mortality and healthcare utilization in the year following a paramedic-attended non-fatal overdose among people who were and were not transported to hospital: A prospective cohort study using linked administrative health data
    McLeod, Katherine E.
    Slaunwhite, Amanda K.
    Zhao, Bin
    Moe, Jessica
    Purssell, Roy
    Gan, Wenqi
    Xavier, Chloe
    Kuo, Margot
    Mill, Chris
    Buxton, Jane A.
    Scheuermeyer, Frank X.
    DRUG AND ALCOHOL DEPENDENCE, 2021, 218
  • [28] Using decision tree models and comprehensive statewide data to predict opioid overdoses following prison release
    Yamkovoy, Kristina
    Patil, Prasad
    Dunn, Devon
    Erdman, Elizabeth
    Bernson, Dana
    Swathi, Pallavi Aytha
    Nall, Samantha K.
    Zhang, Yanjia
    Wang, Jianing
    Brinkley-Rubinstein, Lauren
    Lemasters, Katherine H.
    White, Laura F.
    Barocas, Joshua A.
    ANNALS OF EPIDEMIOLOGY, 2024, 94 : 81 - 90
  • [29] Estimated effects of opioid agonist treatment in prison on all-cause mortality and overdose mortality in people released from prison in Norway: a prospective analysis of data from the Norwegian Prison Release Study (nPRIS)
    Bukten, Anne
    Stavseth, Marianne Riksheim
    LANCET PUBLIC HEALTH, 2024, 9 (07): : e421 - e431
  • [30] Use of hydrochlorothiazide and risk of nonmelanoma skin cancer in Koreans: a retrospective cohort study using administrative healthcare data
    Kim, J. C.
    Kim, Y. C.
    Choi, J. W.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (04) : 680 - 686